Nym Named to New York Digital Health 100 for Third Consecutive Year
NEW YORK--(BUSINESS WIRE)--Nym, the leader in autonomous medical coding, today announced that, for the third year in a row, it...
Day: February 8, 2024
McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...
McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)...
Mile Bluff Medical Center Now Live with MEDITECH Expanse Search and Summarization, Powered by Google Health
Clinicians experience the immediate impact of this AI-powered solution in improving workflowCANTON, Mass.--(BUSINESS WIRE)--Mile Bluff Medical Center (Mauston, WI) just...
Arrive Partners with AllMart Marketplace to Launch its Smart Mailbox Solution in Antigua
Autonomous delivery testing expected to follow in second half of 2024VANCOUVER, BC and INDIANAPOLIS, IN / ACCESSWIRE / February 8,...
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024NORTHVALE, NJ /...
Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing
JACKSON CENTER, PA / ACCESSWIRE / February 8, 2024 / Halberd Corporation's (OTC PINK:HALB) Traumatic Brain Injury (TBI) mitigating nasal...
Innovaccer Recognized as the 2024 Best in KLAS CRM Solution
The data platform company scored 93.6 out of 100 for its CRM solution, and 88+ across all customer experience pillars,...
Avant Brands Executes Four New Export Agreements
KELOWNA, BC / ACCESSWIRE / February 8, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), an award-winning cannabis...
Celebrating Its Fifth Anniversary, Genesis Reference Laboratories Announces Testing Upgrades
Leading diagnostics laboratory Genesis Reference Laboratories, which recently celebrated five years in the industry, is excited to announce it has...
Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Jones Healthcare Group’s Qube Pro Wins Prestigious PAC Global Awards
Innovation and Sustainability Lead to Double Award Win for Qube Pro at PAC GlobalLondon, Ontario--(Newsfile Corp. - February 8, 2024)...
Planet 13 Announces Expansion of Leadership Team and Board
LAS VEGAS, NV / ACCESSWIRE / February 8, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),...
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
ANN ARBOR, MI / ACCESSWIRE / February 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Sai Life Sciences releases its Sustainability Report 2023
Sustainability Report 2023 Sustainability Report 2023 HYDERABAD, India, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, a leading global...
A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius
A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius CMR Surgical launches vLimeLite * a new...
SweetWater Brewing and Atlanta Track Club Join Forces to Promote Active Lifestyles
SweetWater Brewing is now the Official Beer Partner of the Atlanta Track Club SweetWater Brewing Company x Atlanta Track Club...
Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa
• Initial clinical data suggest the potential of B-VEC to treat lesions in the eye of DEB patients and additional...
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
- Award Recognizes Approval of Amicus Therapeutics’ Two-component Therapy for the Treatment of Late-onset Pompe Disease -PRINCETON, N.J., Feb. 08,...
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD
– Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including treatment burden reduction and...